174 related articles for article (PubMed ID: 11137094)
21. Affinity labeling of histamine N-methyltransferase by 2',3'-dialdehyde derivatives of S-adenosylhomocysteine and S-adenosylmethionine. Kinetics of inactivation.
Borchardt RT; Wu YS; Wu BS
Biochemistry; 1978 Oct; 17(20):4145-52. PubMed ID: 708699
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the impact of S-adenosylhomocysteine metabolic pools on cytosine methylation of the tobacco genome.
Fojtová M; Kovarík A; Votruba I; Holý A
Eur J Biochem; 1998 Mar; 252(3):347-52. PubMed ID: 9546648
[TBL] [Abstract][Full Text] [Related]
23. Influence of S-adenosylhomocysteine hydrolase inhibitors on S-adenosylhomocysteine and S-adenosylmethionine pool levels in L929 cells.
Cools M; De Clercq E
Biochem Pharmacol; 1990 Nov; 40(10):2259-64. PubMed ID: 2244927
[TBL] [Abstract][Full Text] [Related]
24. S-adenosylhomocysteine metabolism in different cell lines: effect of hypoxia and cell density.
Hermes M; von Hippel S; Osswald H; Kloor D
Cell Physiol Biochem; 2005; 15(5):233-44. PubMed ID: 15956786
[TBL] [Abstract][Full Text] [Related]
25. S-adenosylmethionine, S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase variations during differentiation of Dictyostelium discoideum.
Guitton MC; Keller BT; Part D; De Gunzburg J; Borchardt RT; Véron M
Cell Differ; 1988 Feb; 22(3):203-10. PubMed ID: 2833354
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency.
Strauss KA; Ferreira C; Bottiglieri T; Zhao X; Arning E; Zhang S; Zeisel SH; Escolar ML; Presnick N; Puffenberger EG; Vugrek O; Kovacevic L; Wagner C; Mazariegos GV; Mudd SH; Soltys K
Mol Genet Metab; 2015; 116(1-2):44-52. PubMed ID: 26095522
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
[TBL] [Abstract][Full Text] [Related]
28. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.
Hermes M; Geisler H; Osswald H; Riehle R; Kloor D
Biochem Pharmacol; 2008 Jun; 75(11):2100-11. PubMed ID: 18395186
[TBL] [Abstract][Full Text] [Related]
29. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine.
Kerins DM; Koury MJ; Capdevila A; Rana S; Wagner C
Am J Clin Nutr; 2001 Dec; 74(6):723-9. PubMed ID: 11722952
[TBL] [Abstract][Full Text] [Related]
30. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.
Perna AF; Ingrosso D; Zappia V; Galletti P; Capasso G; De Santo NG
J Clin Invest; 1993 Jun; 91(6):2497-503. PubMed ID: 8514862
[TBL] [Abstract][Full Text] [Related]
32. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
[TBL] [Abstract][Full Text] [Related]
33. Increase in S-adenosylhomocysteine concentration in interferon-treated HeLa cells and inhibition of methylation of vesicular stomatitis virus mRNA.
de Ferra F; Baglioni C
J Biol Chem; 1983 Feb; 258(4):2118-21. PubMed ID: 6185492
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
[TBL] [Abstract][Full Text] [Related]
35. Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
Hasobe M; McKee JG; Ishii H; Cools M; Borchardt RT; De Clercq E
Mol Pharmacol; 1989 Sep; 36(3):490-6. PubMed ID: 2779528
[TBL] [Abstract][Full Text] [Related]
36. Microsomal phosphatidylethanolamine methyltransferase: inhibition by S-adenosylhomocysteine.
Hoffman DR; Haning JA; Cornatzer WE
Lipids; 1981 Aug; 16(8):561-7. PubMed ID: 7278517
[TBL] [Abstract][Full Text] [Related]
37. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
Fu W; Dudman NP; Perry MA; Young K; Wang XL
Biochem Biophys Res Commun; 2000 Apr; 271(1):47-53. PubMed ID: 10777679
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis.
D'Angelo S; Trojsi F; Salvatore A; Daniele L; Raimo M; Galletti P; Monsurrò MR
Neurochem Int; 2013 Nov; 63(6):626-34. PubMed ID: 24044898
[TBL] [Abstract][Full Text] [Related]
39. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
[TBL] [Abstract][Full Text] [Related]
40. S-Adenosylmethionine Deficiency and Brain Accumulation of S-Adenosylhomocysteine in Thioacetamide-Induced Acute Liver Failure.
Czarnecka AM; Hilgier W; Zielińska M
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32709137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
